Siegfried Holding AG
SFZN: XSWX (CHE)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
CHF 4,717.00 | Bsbbtr | Nnmggbwrq |
Siegfried: Benefits From Healthy Drug Outsourcing Demand; Fair Value Estimate of CHF 1,020
We are launching coverage of Siegfried Holding, a leading global contract development and manufacturing organization, or CDMO. We assign Siegfried a fair value estimate of CHF 1,020 and a narrow economic moat rating based on high customer switching costs, as the challenges associated with changing a drug's manufacturing process make customers unlikely to switch to a different CDMO.